Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-036102

Chief Financial Officer sold 281 shares at $162.66 ($45,707)

  • Chief Financial Officer acquired 8,935 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-19 Grant or award : show line 1 in the form +8,935 39,292 D
2021-05-24 Sale : show line 2 in the form −281 $162.66 $45,707 39,011 D
Open-market sales · 281 sh · avg $162.66 · $45,707

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-19 Grant or award : show line 3 in the form Stock Option (right to buy) +22,338 $177.76 2031-03-19 22,338 22,338 D
Loading xslF345X03/doc4.xml…